Publication | Closed Access
Highly Enantioselective Organocatalytic Addition of Aldehydes to <i>N</i>‐(Phenylmethylene)benzamides: Asymmetric Synthesis of the Paclitaxel Side Chain and Its Analogues
58
Citations
81
References
2009
Year
Bioorganic ChemistryPaclitaxel Side ChainOrganic ChemistryEnantioselective Organocatalytic AdditionChemistryEsterification-ready Phenylisoserine DerivativesPharmaceutical ChemistryMedicinal ChemistryNovel OrganocatalystsAnti-cancer AgentBiochemistryAsymmetric SynthesisSubsequent Phenylisoserine DerivativesPharmacologyNatural Product SynthesisAsymmetric CatalysisEnantioselective SynthesisPaclitaxel AnaloguesNatural SciencesMedicineSynthetic ChemistryDrug Discovery
Easily side-tracked: A simple route to the paclitaxel side chain and its analogues is based on the (R)-proline-catalyzed addition of aldehydes to N-(phenylmethylene)benzamides, followed by oxidation of the resulting protected alpha-hydroxy-beta-benzoylaminoaldehydes (92-99 % ee). Esterification of the subsequent phenylisoserine derivatives with baccatin III gives paclitaxel analogues (see scheme).A simple highly enantioselective organocatalytic addition of aldehydes to N-(phenylmethylene)benzamides is presented. The application of (R)-proline as the catalyst and subsequent oxidation of the protected alpha-hydroxy-beta-benzoylaminoaldehydes (92-99 % ee) gives access to esterification-ready phenylisoserine derivatives such as the protected paclitaxel (taxol) side chain. Esterification of these derivatives with baccatin III gives access to the cancer chemotherapeutic substance paclitaxel and its analogues that do not exist in nature.
| Year | Citations | |
|---|---|---|
Page 1
Page 1